• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Re-emergence of amantadine-resistant variants among highly pathogenic avian influenza H5N1 viruses in Egypt

tetano

Editor, Senior Moderator
Infect Genet Evol. 2016 Oct 29;46:102-109. doi: 10.1016/j.meegid.2016.10.022. [Epub ahead of print]
[h=1]Re-emergence of amantadine-resistant variants among highly pathogenic avian influenza H5N1 viruses in Egypt.[/h] El-Shesheny R[SUP]1[/SUP], Bagato O[SUP]2[/SUP], Kandeil A[SUP]2[/SUP], Mostafa A[SUP]2[/SUP], Mahmoud SH[SUP]2[/SUP], Hassanneen HM[SUP]3[/SUP], Webby RJ[SUP]4[/SUP], Ali MA[SUP]5[/SUP], Kayali G[SUP]6[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Highly pathogenic avian influenza (HPAI) H5N1 virus continues to undergo substantial evolution. Emergence of antiviral resistance among H5N1 avian influenza viruses is a major challenge in the control of pandemic influenza. Numerous studies have focused on the genetic and evolutionary dynamics of the hemagglutinin and neuraminidase genes; however, studies on the susceptibility of HPAI H5N1 viruses to amantadine and genetic diversity of the matrix (M) gene are limited. Accordingly, we studied the amantadine susceptibility of the HPAI H5N1 viruses isolated in Egypt during 2006-2015 based on genotypic and phenotypic characteristics. We analyzed data on 253 virus sequences and constructed a phylogenetic tree to calculate selective pressures on sites in the M2 gene associated with amantadine-resistance among different clades. Selection pressure was identified in the transmembrane domain of M2 gene at positions 27 and 31. Amantadine-resistant variants emerged in 2007 but were not circulating between 2012 and 2014. By 2015, amantadine-resistant HPAI H5N1 viruses re-emerged. This may be associated with the uncontrolled prescription of amantadine for prophylaxis and control of avian influenza infections in the poultry farm sector in Egypt. More epidemiological research is required to verify this observation.
Copyright ? 2016 Elsevier B.V. All rights reserved.


[h=4]KEYWORDS:[/h] Amantadine-resistant; Egypt; H5N1 viruses

PMID: 27876611 DOI: 10.1016/j.meegid.2016.10.022
[PubMed - as supplied by publisher]
 
Back
Top Bottom